These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 19338997

  • 1. Increased secretion of amylin in women with polycystic ovary syndrome.
    James S, Moralez J, Nagamani M.
    Fertil Steril; 2010 Jun; 94(1):211-5. PubMed ID: 19338997
    [Abstract] [Full Text] [Related]

  • 2. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 3. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V, Nagamani M.
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [Abstract] [Full Text] [Related]

  • 4. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 5. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC.
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [Abstract] [Full Text] [Related]

  • 6. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 7. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 8. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF, Zhu JP, Zhou J, Lu W, Qin W, Teng YC, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):659-63. PubMed ID: 19595057
    [Abstract] [Full Text] [Related]

  • 9. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
    Diamanti-Kandarakis E, Economou FN, Livadas S, Tantalaki E, Piperi C, Papavassiliou AG, Panidis D.
    Kidney Blood Press Res; 2009 Mar 17; 32(1):24-31. PubMed ID: 19212122
    [Abstract] [Full Text] [Related]

  • 10. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
    Carmina E, Lobo RA.
    Fertil Steril; 2004 Sep 17; 82(3):661-5. PubMed ID: 15374711
    [Abstract] [Full Text] [Related]

  • 11. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M, Aydemir M, Tuzcu A.
    Fertil Steril; 2007 Jun 17; 87(6):1363-8. PubMed ID: 17362944
    [Abstract] [Full Text] [Related]

  • 12. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA.
    Fertil Steril; 2004 Mar 17; 81(3):624-9. PubMed ID: 15037412
    [Abstract] [Full Text] [Related]

  • 13. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC.
    Am J Obstet Gynecol; 2007 Apr 17; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [Abstract] [Full Text] [Related]

  • 14. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
    Guido M, Romualdi D, De Marinis L, Porcelli T, Giuliani M, Costantini B, Lanzone A.
    Fertil Steril; 2007 Jul 17; 88(1):125-30. PubMed ID: 17276431
    [Abstract] [Full Text] [Related]

  • 15. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep 17; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

  • 16. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D, De Marinis L, Campagna G, Proto C, Lanzone A, Guido M.
    Clin Endocrinol (Oxf); 2008 Oct 17; 69(4):562-7. PubMed ID: 18248643
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
    Fertil Steril; 2007 Jul 17; 88(1):131-8. PubMed ID: 17336978
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G.
    Clin Endocrinol (Oxf); 2005 Jan 17; 62(1):37-43. PubMed ID: 15638868
    [Abstract] [Full Text] [Related]

  • 19. Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.
    Ehrmann DA, Breda E, Corcoran MC, Cavaghan MK, Imperial J, Toffolo G, Cobelli C, Polonsky KS.
    Am J Physiol Endocrinol Metab; 2004 Aug 17; 287(2):E241-6. PubMed ID: 14665448
    [Abstract] [Full Text] [Related]

  • 20. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.